Tumor Board Review: Evidence-Based Case Reviews and Questions

As the field of medical oncology evolves, we have developed a new format for the third edition
of this textbook, now titled: Tumor Board Review: Evidence-Based Case Reviews and
Questions. Here we include recent advances in the diagnosis and treatment of the most common
malignancies encountered by oncology providers. The text includes recently published
clinical studies and updated cancer guidelines. Further, we discuss the importance of genetic
mutations in the selection of anticancer drugs (e.g., BRAF mutations in melanoma) based on
Phase III clinical trials in both solid tumors and hematologic malignancies. The content of this
third edition represents our best effort to incorporate and highlight the most recent clinically
relevant data in our field. We continue to use a case-based format, but each oncologic disease
type is now presented in a tumor board format, with a brief synopsis of a patient case followed
by a discussion of the imaging and molecular and/or genomic sequencing required for a correct
diagnosis. We finish each chapter with a dialogue on staging and treatment including chemotherapy,
immunotherapy, and targeted agent regimens. Finally, we close with pertinent information
related to follow-up and survivorship. Up to 10 board-style questions are also included
at the end of each chapter to help enhance the reader's knowledge base.